Wells Fargo
BTX.WS

Wells Fargo’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Wells Fargo’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-240
Closed – – 6746
2018
Q2 		$0 Sell
240
-254
-51% -$19 ﹤0.01% 6769
2018
Q1 		$0 Buy
494
+204
+70% +$30 ﹤0.01% 6727
2017
Q4 		$0 Sell
290
-4
-1% -$1 ﹤0.01% 6682
2017
Q3 		$0 Hold
294
– – ﹤0.01% 6608
2017
Q2 		$0 Buy
294
+127
+76% +$54 ﹤0.01% 6620
2017
Q1 		$0 Hold
167
– – ﹤0.01% 6662
2016
Q4 		$0 Buy
167
+28
+20% +$19 ﹤0.01% 6591
2016
Q3 		$0 Buy
139
+14
+11% +$7 ﹤0.01% 6475
2016
Q2 		$0 Buy
125
+50
+67% +$27 ﹤0.01% 6508
2016
Q1 		$0 Sell
75
-139
-65% -$94 ﹤0.01% 6589
2015
Q4 		$0 Hold
214
– – ﹤0.01% 6552
2015
Q3 		$0 Hold
214
– – ﹤0.01% 6604
2015
Q2 		$0 Sell
214
-26
-11% -$50 ﹤0.01% 6628
2015
Q1 		$0 Sell
240
-7
-3% -$9 ﹤0.01% 6491
2014
Q4 		$0 Buy
+247
New +$268 ﹤0.01% 6541

Wells Fargo's BTX.WS Position: Q3 2018 in Review

Wells Fargo sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 240 shares.

Wells Fargo first reported a position in BTX.WS in Q4 2014 and held it in 15 quarters. The position peaked at $0 in Q2 2018. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • Wells Fargo reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • Wells Fargo sold 240 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018.
  • Wells Fargo first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 15 quarters.
  • Wells Fargo's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q2 2018.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on Wells Fargo's 13F filing for Q3 2018, filed 2 Nov 2018.